Perioperative blood conservation

European Journal of Anaesthesiology

Volumn 26, Issue 9, 2009, Pages 722-729

  Cardone, David ^a   Klein, Andrew A ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; BLOOD SUBSTITUTE; DESMOPRESSIN; HEMOSTATIC AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT ERYTHROPOIETIN; TRANEXAMIC ACID; ARGIPRESSIN[1 DEAMINO]; BLOOD CLOTTING FACTOR 7A; ERYTHROPOIETIN; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ANESTHESIOLOGICAL TECHNIQUES; BLOOD AUTOTRANSFUSION; BLOOD CONSERVATION; BLOOD TRANSFUSION; BLOOD VOLUME; CENTRAL VENOUS PRESSURE; CLINICAL PRACTICE; CLINICAL PROTOCOL; ERYTHROCYTE; HEMODILUTION; HUMAN; HYPOTENSION; MEDICAL AUDIT; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; REFRACTORY ANEMIA; REVIEW; SURGICAL PATIENT; SURGICAL TECHNIQUE; HEMOSTASIS; METHODOLOGY;

ANTIFIBRINOLYTIC AGENTS; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; DEAMINO ARGININE VASOPRESSIN; ERYTHROPOIETIN; FACTOR VIIA; GUIDELINES AS TOPIC; HEMODILUTION; HEMOSTASIS, SURGICAL; HUMANS; PERIOPERATIVE CARE; RECOMBINANT PROTEINS;

EID: 70349119744     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832c5280     Document Type: Review

References (60)

1. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007; 356:2301-2311.
2. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Blood transfusion. N Engl J Med 1999; 340:438-446.
3. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004; 44:1453-1462.
4. National Blood Services. NBS price lists. Commissioning and finance area. NBS National blood and blood components price list 2008-09. http://hospital.blood.co.uk/products/ordering-issue-products/index.asp.
5. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 1997; 85:1258-1267.
6. Fremes SE, Wong BI, Lee E, et al. Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994; 58:1580-1588.
7. Fergusson D, Glass KC, Hutton B, Shapiro S. Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding? Clin Trials 2005; 2:218-219.
8. Henry DA, Careless PA, Moxey AJ, et al. Antifibrinolytic use for minimising perioperative allogenic blood transfusion. Cochrane Database Syst Rev 2007; CD001886.
9. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999; 354:1940-1957.
10. Sedrakyan A, Treasure T, Elefefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis ofrandomized clinical trials. J Thorac Cardiovasc Surg 2004; 128:442-448.
11. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354:353-365.
12. Brown JR, Birkmeyer NJO, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007; 115:2801-2813.
13. Careless PA, Moxey AJ, Stokes BJ, Henry DA. Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomised head-to-head trials. BMC Cardiovasc Disord 2005; 5:19.
14. Fergusson DA, Hebert PC, Mazer D, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358:2319-2331.
15. Katsaros D, Petricevic M, Snow NJ, et al. Tranexamic acid reduces postbypass blood use: a double-blind, prospective, randomised study of 201 patients. Ann Thorac Surg 1996; 61:1131-1135.
16. Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev 2008; CD006883.
17. Careless PA, Henry DA, Moxey AJ, et al. Desmopressin for minimising perioperative allogenic blood transfusion. Cochrane Database Syst Rev 2003; CD001884.
18. Ranucci M, Isgro G, Soro G, et al. Efficacy and safety of recombinant activated factor VII in major surgical procedures. Systematic review and meta-analysis of randomised clinical trials. Arch Surg 2008; 143:296-304.
19. Ahonen J, Jokela R. Recombinant factor Vila for life-threatening postpartum haemorrhage. Br J Anaesth 2005; 94:592-595.
20. Bouwmeester FW, Jonkhoff AR, Verheijen RH, van Geijn HP. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 2003; 101:1174-1176.
21. Danilos J, Goral A, Paluszkiewicz P, et al. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery. Obstet Gynecol 2003; 101 :1172-1173.
22. Dunkley SM, Mackie F. Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent. Hematology 2003; 8:263-264.
23. Flynn JD, Pajoumand M, Camp PC Jr, et al. Recombinant factor VIIa for refractory bleeding following orthotopic heart transplantation. Ann Pharmacother 2004; 38:1639-1642.
24. Crosby E. Perioperative use of erythropoietin. Am J Ther 2002; 9:371-376.
25. Goodnough LT, Price TH, RudnickS, et al. Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992; 32:441-445.
26. Careless PA, Anthony DM, Henry DA. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion. Br J Surg 2002; 89:695-703.
27. Goodnough LT. Autologous blood donation. Anesthesiol Clin North Am 2005; 23:263-270.
28. Carless PA, Moxey A, O'Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med 2004; 14:123-144.
29. Henry DA, Careless PA, Moxey AJ, et al. Preoperative autologous donation for minimising perioperative allogeneic blood transfusion [review]. Cochrane Database Syst Rev 2001; CD003602.
30. Boulton FE, James V. Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion: British Committee for Standards in Haematology, Transfusion Task Force. Transfus Med 2007; 17:354-365.
31. Tseliou P, Apostolopoulos DJ, Chronopoulos G, et al. Experience with predeposition of autologous blood in elective orthopaedic and plastic surgery: the role oforal iron medication. Haematologia 2002; 32:355-361.
32. Canadian Orthopaedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993; 341 :1227-1232.
33. Price TH, Goodnough LT, Vogler WR, et al. Improving the efficacy of preoperative autologous blood donation in patients with low haematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin. Am J Med 1996; 101 (Suppl 2A):22s-27s.
34. Stowell CP, Chandler H, Jove M, et al. An open label randomized study to compare the safety and efficacy of perioperative epoetin alfa with perioperative autologous blood donation in total joint arthroplasty. Orthopaedics 1999; 22 (Suppl 1):s105-s112.
35. Laupacis A, Fergusson D. Erythropoieitn to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Perioperative Transfusion (ISPOT) Investigators. Transfus Med 1998; 8:309-317.
36. Monk TG. Acute normovolemic haemodilution. Anesthesiol Clin North Am 2005; 23:271-281.
37. Jamnicki M, Kocian R, van der Linden P, et al. Acute normovolaemic haemodilution: physiology, limitations, and clinical use. J Cardiothorac Vasc Anesth 2003; 17:747-754.
38. Gross JB. Estimating allowable blood loss: correction for dilution. Anesthesiology 1983; 58:277-280.
39. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279:217-221.
40. Olsfanger D, Fredman B, Goldstein B, et al. Acute normovolaemic haemodilution decreases postoperative allogeneic blood transfusion after total knee replacement. Br J Anaesth 1997; 79:317-321.
41. Matot I, Scheinin O, Jurim O, et al. Effectiveness of acute normovolaemic haemodilution to minimise allogeneic blood transfusion in major liver resections. Anesthesiology 2002; 97:794-800.
42. Kochamba GS, Pfeffer TA, Sintek CF, et al. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. Ann Thorac Surg 1996; 61 :900-903.
43. Helm RE, Klemperer JD, Rosengart TK, et al. Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. Ann Thorac Surg 1996; 62:1431-1441.
44. Hohn L, Schweizer A, Licker M, Morel DR. Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery. Anesthesiology 2002; 96:276-282.
45. Kahraman S, Altunkaya H, Celebioglu B, et al. The effect of acute normovolemic hemodilution on homologous blood requirements and total estimated red blood cell volume lost. Acta Anaesthesiol Scand 1997; 41 :614-617.
46. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E. Perioperative acute normovolaemic haemodilution: a meta-analysis. Transfusion 2004; 44:632-644.
47. Ferraris VA, Ferraris SP, Sibu PS, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83:27-86.
48. Huet C, Salmi LR, Fergusson D, et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. Anesth Analg 1999; 89:861-869.
49. Munoz M, Campos A, Munoz E, et al. Red cell salvage in orthopedic surgery. Transfus Altern Transfus Med 2006; 8:141-151.
50. Orlinsky M, Shoemaker W, Reis ED, Kerstein MD. Current controversies in shock and resuscitation. Surg Clin North Am 2001; 81 :1217-1262.
51. Goodnough LT, Brecher ME, Kanter MH, Au Buchon JP. Transfusion medicine. Blood Conservation. N Engl J Med 1999; 340:525-533.
52. Careless PA, Henry DA, Moxey AJ, et al. Cell salvage for minimizing perioperative allogeneic blood transfusion [review]. Cochrane Database Syst Rev 2006; CD001888.
53. Klein AA, Nashef SAM, Sharples L, et al. A randomized controlled trial of cell salvage in routine cardiac surgery. Anesth Analg 2008; 107:1487-1495.
54. Degoute CS. Controlled hypotension: a guide to drug choice. Drugs 2007; 67:1053-1076.
55. Sharrock NE, Mineo R, Urquhart B, Salvati EA. The effect of two levels of hypotension on intraoperative blood loss during total hip arthroplasty performed under lumbar epidural anesthesia. Anesth Analg 1993; 76:580-584.
56. Shander A. Surgery without blood. Crit Care Med 2003; 31 (Suppl 12): S708-S714.
57. Smyrniotis V, Kostopanagiotou G, Theodoraki K, et al. The role of central venous pressure and type ofvascular control in blood loss during major liver resections. Am J Surg 2004; 187:398-402.
58. Heaton N. Advances and methods in liver surgery: haemostasis. Eur J Gastroenterol Hepatol 2005; 17 (Suppl 1):S3-S12.
59. BCSH Blood Transfusion Taskforce. Guidelines for the clinical use of red cell transfusions. Br J Haematol 2001; 113:24-31.
60. Toy PTCY. Effectiveness of transfusion audits and practice guidelines. Arch Pathol Lab Med 1994; 118:435-437.